CMS had until Feb. 1 to announce the new batch of drugs chosen ... The drugs treat conditions such as diabetes and cancer, and seniors across the country rely on them,” President Joe Biden said in a statement. “The Inflation Reduction Act put the ...

The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started, so current drug prices are unaffected.

Famous and renowned strategist of the Democrats named James Carville quite recently asserted that no one in the US right now wants to hear anything whatsoever from former US President Joe Biden. He also said that due to some significant reasons everyone out there just hates former US President Joe Biden.

Among the dozens of Biden-era executive orders he rescinded on day one, President Trump nixed one that aimed to explore new health care payment models that would lower prescription costs for

President Trump is rolling back Biden healthcare policies, such as expansions to the Affordable Care Act – a move Democrats described as an "attack" on the federal program.

On Day 1 of his second term of office, Trump rescinded Biden's Executive Order 14087, "Lowering Prescription Drug Costs for Americans." Trump's action ha

The rescinded orders include directives boosting the Affordable Care Act exchanges, coordinating the government’s COVID-19 response and overseeing artificial intelligence tools.

Barron Trump caught attention at the inauguration for his height and polite demeanor, exchanging greetings with Joe Biden and Kamala Harris. Social me

The Biden administration unveiled its list of 15 drugs, which include GLP-1 drugs Ozempic, Wegovy and Rybelsus, for the second round of drug price negotiations, made possible through the Inflation | Likely to be the last defining health policy act as president,

Social media users observed Joe Biden’s presidential tenure missing from Google’s search results, with only Donald Trump’s terms visible. Screenshots

Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.

Activist investor Ancora Holdings plans a proxy battle at U.S. Steel, urging the company to abandon its merger with Japan's Nippon Steel. Ancora also seeks the removal of CEO David Burritt and has nominated nine new board candidates,